AI Prediction of Post-Induction Hypotension in Cesarean Sections With Spinal Anesthesia

March 5, 2024 updated by: Samet Yavuzel, Hacettepe University

Development of an Artificial Intelligence Algorithm to Predict Hypotension Risk After Induction in Cesarean Sections With Spinal Anesthesia

The cesarean section, medically necessary for both the mother and the baby in certain cases, is a life-saving operation.The most commonly used anesthesia method worldwide is spinal anesthesia. While spinal anesthesia has many advantages, it also has disadvantages. One of the most commonly encountered disadvantages is the development of hypotension due to the unopposed parasympathetic response after induction. Determining which patient will develop hypotension and which patient will not remains an important question for anesthesiologists before surgery. Identifying high-risk patients for hypotension before starting spinal anesthesia and even knowing the percentage of patients who will develop hypotension undoubtedly saves time in problem-solving. From this perspective, the idea for this study emerged: identifying parameters with the potential for use in prediction based on the literature, collecting data, then testing the relationship between them using machine learning methods, and developing an algorithm capable of predictive analysis.

At the end of the study, an artificial intelligence algorithm for predicting hypotension after induction will be developed, and its performance will be tested.

The main goals of the study:

i)Create a dataset including the clinical characteristics, demographic data, and blood test results of patients who develop and do not develop hypotension after spinal anesthesia.

ii) Develop an artificial intelligence algorithm using the dataset and determine the most accurate algorithm for predicting hypotension.

iii) To test the accuracy of the developed algorithm, create a test dataset, measure and optimize the algorithm's performance. Accuracy, sensitivity, specificity, and Receiver Operating Characteristic (ROC) curves will be used for performance measurement.

iv) Create a suitable interface (a surface for interaction with the software) to make the developed algorithm usable in clinical practice.

Study Overview

Detailed Description

Rationale: Cesarean section, when indicated correctly, is a childbirth method that preserves the health of both the mother and the baby. The rates of births by cesarean section have been increasing worldwide for years. Between 2010 and 2018, 21.1% of globally tracked births were performed by cesarean section. According to the World Health Organization (WHO), it is expected that this rate will increase, reaching 29% by the year 2030.

The anesthesia for cesarean section is fundamentally influenced by both the physiological and pathological changes induced by pregnancy in the mother's body. Changes occurring during pregnancy and childbirth, and the resulting differences, can present challenges for anesthesiologists.

Spinal anesthesia induces iatrogenic sympathetic blockade, reducing systemic vascular resistance along with arterial and venous vasodilation, leading to hypotension. The incidence of hypotension after spinal anesthesia in pregnant women ranges from 7.4% to 74%. The frequency of hypotension is higher in pregnant women due to factors such as supine hypotension syndrome caused by fetal inferior vena cava compression and the development of collateral venous plexus in the epidural area, leading to the ascent of intrathecal local anesthetic in the cerebrospinal fluid. The deepening of hypotension and bradycardia in the patient can result in cardiac collapse, fetal hypoxia, and acidosis, posing an unpredictable risk to both maternal and fetal health. The role of anesthesiologists is to prevent or manage this risky condition effectively.

Recent advances in deep learning and artificial intelligence (AI) have found their place in the field of anesthesia. AI applications in anesthesia can be categorized into five main areas: 1) Monitoring the depth of anesthesia (e.g., techniques analyzing EEG data during anesthesia), 2) Control of anesthetic drug delivery based on depth of anesthesia, 3) Event prediction, 4) Ultrasound guidance, and 5) Pain management.

Among these applications, event prediction is particularly critical for anesthesiologists. Knowing about an event before it occurs contributes to its prevention or enables more accurate management. There have been 53 studies in the literature using AI for event prediction, including studies developing algorithms to predict hypotension during surgery and validating these algorithms. What sets this project apart from existing studies are:

These studies have not been specifically developed to predict spinal anesthesia-induced hypotension during cesarean sections.

These studies have mostly used wave analysis (non-invasive or invasive) for predicting hypotension. In this project, this approach will not be utilized. Preoperative assessments will be conducted, and patient characteristics will be recorded. Therefore, the resulting algorithm will not be a dynamic/real-time data input algorithm.

AI and its subset, machine learning algorithms, impact every aspect of our lives. In the medical field, it has become a method, especially in reducing human error in clinical decision-making.

In this study, demographic information, vital signs, specific blood parameters, and certain characteristics related to the administration of spinal anesthesia will be systematically recorded for pregnant women undergoing spinal anesthesia. Blood parameters include complete blood count, serum electrolytes, liver enzyme levels (ALT/AST), and Syndecan-1. All blood parameters are listed in the original study protocol. Syndecan-1 is a molecule shed into the serum with the degradation or damage of the vascular endothelial glycocalyx layer. Particularly, it rises during volume loading, sepsis, or inflammatory processes. Serum Syndecan-1 levels increase as the weeks of pregnancy progress, with the most significant increase occurring between the 20th and 30th weeks. If preeclampsia develops in the later stages of pregnancy, Syndecan-1 levels decrease.

In a study examining the preoperative and postoperative levels of Syndecan-1 in cesarean section patients who underwent spinal anesthesia, a significant difference was found. The study concluded that preoperative prophylactic fluid bolus administration affected endothelial glycocalyx degradation. Based on this study, Syndecan-1 has the theoretical potential to be a new marker for predicting hypotension. Although Syndecan-1 has been studied in pregnant women before, there is no study in the literature examining the relationship between preoperative Syndecan-1 levels and hypotension during spinal anesthesia in cesarean section patients. This study will both investigate the relationship between Syndecan-1 and hypotension and evaluate its place in the developed algorithm.

After recording the initial data for each patient, the development of hypotension will be observed and documented. The collected data will be analyzed to examine the relationships between the occurrence or non-occurrence of hypotension after induction. Additionally, an artificial intelligence algorithm will be developed using this data. The primary aim is to develop the algorithm. During the study, there will be no changes in the anesthesia management applied to the pregnant women.

In this context, the developed algorithm aims to early identify hypotension caused by spinal anesthesia (predicting the risk of hypotension before the operation starts) and enable early initiation of treatment.

Method:

Time of the Project: The ethical approval for the project has been granted by the Hacettepe University Non-Interventional Clinical Research Ethics Board. The project is planned to be conducted between November 2023 and April 2024.

Methodology and Data Collection Tools of the Project:

Data of patients meeting the inclusion criteria in the Operating Room will be obtained from routine test results sent after hospitalization for cesarean section, preoperative nurse observation forms, and records of vital signs monitored by anesthesia during surgery. After the patient is taken to the operating room, the information in the Data Collection Form will be filled out by the anesthesiologist. The duration of hypotension after spinal anesthesia begins immediately after anesthesia administration in pregnant women, reaching its lowest level within approximately 10-15 minutes. It is known to return to normal within 20-30 minutes. However, the duration of hypotension can vary depending on factors such as gestational age, anesthesia dose, overall health status of the patient, and other factors. Especially in pregnant women with high anesthesia doses or hypertension, the duration of hypotension can be longer . Therefore, the duration of hypotension needs to be evaluated individually for each patient. However, in this study, observation for the first 15 minutes is preferred. This preference is made because the algorithm predicts spinal-induced hypotension based on preoperative characteristics. With the extended observation period, the occurrence of childbirth, the increase in cardiac output, and the initiation of oxytocin infusion during the operation make hemodynamics a complex situation affected by multiple independent factors. Data collection will end after the first 15 minutes, and hypotension occurring after the 15th minute will not be recorded for the study; the observation will be terminated.

Collection of Project Data:

Before patients are taken to the operating room, an adequate amount of blood will be drawn from the routine pre-delivery blood samples taken from the patient for the blood parameters . Except for Syndecan-1, the other parameters in the blood parameters are routine tests routinely performed in the Hacettepe University Hospital Biochemistry laboratories.

When measuring syndecan-1, absorbance readings will be conducted using the SpectraMax-M2 (Molecular Devices, USA) device located in the Department of Biochemistry at Hacettepe University. Subsequently, serum syndecan-1 levels will be calculated using the GraphPad Prism program based on the standard graph. The procurement of the necessary ELISA kits for syndecan-1 measurement will be carried out through funding obtained from Hacettepe University's Scientific Research and Project Office.

Data Analysis:

Throughout the steps of algorithm development, the Python programming language will be used. The development process of the artificial intelligence algorithm will follow the Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View guideline. The steps are as follows:

  • Data Collection: Data will be recorded by filling out the Data Collection Form.
  • Data Processing: After data collection, the data will be processed, and it will be randomly split into training data and internal validation data. The data will be cleaned of artifacts and misreadings.
  • Annotation: Data will be labeled for the classification of artificial intelligence, and the definition of hypotension will be annotated. Studies will be conducted to determine the potential of detecting hypotension with artificial intelligence.
  • Feature Selection: Features that predict annotated events to the highest extent will be chosen. One or more feature selection algorithms will be used for this process, and features will be selected based on the success achieved in the models.
  • Model Creation: The most relevant features in the data will be selected, and a model will be developed. Fundamental classification algorithms such as K-Nearest Neighbors, Support Vector Machines (SVM), Decision Trees, Random Forest, commonly used for classification processes in the literature, will be employed to obtain basic performance ratios. Subsequently, a deep learning method will be developed, and the performance difference between the proposed method and the basic methods will be examined

Cross-Validation: The performance of the initial version of the model will be repeatedly subjected to cross-validation with subgroups of data that the model has never seen before. This will determine the model's performance by examining performance changes as the data varies. Depending on the data size, either 10-fold Cross-Validation or 5-fold Cross-Validation methods will be employed.

Internal Validation: The predictive performance of the algorithm trained with the training data will be assessed using internal validation data that it has never encountered.

In addition to the algorithm development process, if the variables being compared are normally distributed, statistical tests such as ANOVA; Student's t-test and Mann-Whitney U test will be used based on the number of compared groups and the normal distribution analysis of variables. Pearson Correlation Analysis and Spearman Correlation Analysis will be used to analyze the relationship between hypotension values and other continuous parameters based on the normal distribution analysis of variables. Moreover, the predictability of the system will be tested using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), odds ratio (OR), risk ratio (RR), receiver operating characteristic curve and area under the curve (AUROC), and Pearson correlation coefficient (r) tests. A statistical significance level of p<0.05 will be accepted. For statistical analysis, the Statistical Packages for the Social Sciences v26.0 (SPSS Inc., Chicago, IL) software will be used.

Study Type

Observational

Enrollment (Estimated)

370

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Altındağ
      • Ankara, Altındağ, Turkey, 06230
        • Recruiting
        • Hacettepe University Hospitals
        • Contact:
        • Principal Investigator:
          • Banu Kılıçaslan, MD
        • Sub-Investigator:
          • Okan Bilge Ozdemir, PhD
        • Sub-Investigator:
          • Yesim Er Oztas, MD, PhD
        • Sub-Investigator:
          • Esin Oz, Research Ass.
        • Sub-Investigator:
          • Basak Akca, MD
        • Sub-Investigator:
          • Murat Cagan, MD
        • Principal Investigator:
          • Samet Yavuzel, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The pregnant women at the delivery ward of Hacettepe University Hospital who have undergone a decision for cesarean section

Description

Inclusion Criteria:

  • Being 18 years or older
  • Having an American Society of Anesthesiologists (ASA) physical status of I, II, or III
  • Gestational age of 37 weeks or more
  • Having undergone spinal or combined spinal-epidural anesthesia

Exclusion Criteria:

  • Patient's unwillingness to participate in the study
  • Multiple pregnancies
  • Emergency cesarean section
  • Preeclampsia
  • Preoperatively measured systolic blood pressure equal to or greater than 140mmHg (hypertensive pregnant woman)
  • Having a contraindication to spinal anesthesia or experiencing spinal anesthesia failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
The women meeting the inclusion criteria, undergoing cesarean section
Women who meet the inclusion criteria and have undergone spinal anesthesia for cesarean section between November 2023 and March 2024
After standard monitoring, the patient is placed in a sitting position for site marking and administration of anesthesia. The line connecting the upper border of the right and left iliac crests through conventional palpation of anatomical landmarks (Tuffier line) is identified as the entry point at the L3-L4 interspinous space or L2-L3 interspace. For patients in whom spinal entry is successful, spinal anesthesia is provided with the appropriate dose and types of local anesthetics (intrathecal 10-12 mg bupivacaine with the addition of 15-25 mcg fentanyl). After completing the procedure and placing the patient in the supine position, the block level is determined 10 minutes post-procedure using the ice test/pinprick test. Blocks reaching the T4-T6 level are considered successful.
Preoperatively, syndecan-1 serum levels will be investigated from the blood sample taken before cesarean section.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Low Blood Pressure Measured by Non-Invasive Methods
Time Frame: The first 15 minutes after the administration of spinal anesthesia
Mean arterial pressure falling below 65 mmHg • Systolic blood pressure dropping below 80 mmHg • Systolic blood pressure falling below 75% of baseline • Onset of hypotension symptoms such as dizziness, increased salivation, shortness of breath, nausea, and vomiting.
The first 15 minutes after the administration of spinal anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The doses of vasopressors used for the treatment of hypotension
Time Frame: The first 15 minutes after the administration of spinal anesthesia.
The doses of vasopressors used for the treatment of hypotension
The first 15 minutes after the administration of spinal anesthesia.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Banu Kilicaslan, Professor, MD, Hacettepe University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 24, 2023

Primary Completion (Actual)

February 9, 2024

Study Completion (Estimated)

May 24, 2024

Study Registration Dates

First Submitted

November 28, 2023

First Submitted That Met QC Criteria

November 28, 2023

First Posted (Actual)

December 6, 2023

Study Record Updates

Last Update Posted (Estimated)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

till submission

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Anesthesia Induced Hypotension

Clinical Trials on Spinal Anesthesia

3
Subscribe